Form 4 for IRON Disc Medicine, Inc.
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-09 · accession 0001586788-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-11 | 2025-09-09 | IRON | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +10.0K | 171.8K | +6% | +$10.1K |
| D | 2025-09-11 | 2025-09-09 | IRON | Quisel John D | CEO, Dir | M - OptEx | $0.00 | -10.0K | 198.4K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-09 | M | A | 10,000 | $1.01 | 171,828 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-09-09 | M | D | 10,000 | $0.00 | 198,420 | D | $1.01 · — to 2030-03-10 | 10,000 Common Stock | (F1) The shares underlying this option are fully vested and exercisable as of the date hereof. |